Document:

Exhibit
10.12

 

	
  

  	
  

  

 

	
  December 28, 2005

  	
   

  
	
  Sue Barrow Welsh

  	
   

  
	
  66 Maybury Hill Road

  	
   

  
	
  Princeton. NJ 08540

  	
  via fedex : (609) 430 1957

  

 

Dear Sue:

On behalf of the Board of
Directors, I am pleased to offer you the position of President with Linguagen
Corp. (“Linguagen” or the “Company”). This letter sets forth the terms of your
employment by the Company, with your first day of employment being January 3,
2006.

1.                                       Position,
Duties and Responsibilities

a.               You
will report to the Chief Executive Officer of the Company.

b.              Your
duties will include, but not be limited to business development strategy &
execution, and product strategy & development, according to a plan
developed in consultation with the remainder of the management team and
approved by the CEO, exploratory projects, plus other responsibilities and
duties as assigned. In addition, you will assist other members of the senior
management team in the fundraising and investor relations activities.

c.               On
or before your first day of employment, you shall sign the Company’s
Confidentiality, Nondisclosure, Noncompetition and Invention Assignment
Agreement for employees, a copy of which is attached hereto as Exhibit A.

2.                                       Salary
and Bonus Compensation

a.               Base
Salary: Your base salary will be $21,666.66 per month ($260,000/year), payable
bi-weekly. This base salary may be adjusted annually by the Board beginning in
January 2007, consistent with your performance and the Company’s policy
regarding adjustments in officer compensation established from time to time by
the Board.

b.              Bonus
Compensation. You will, in addition, be eligible for a cash bonus of up to
thirty per cent (30%) of your base salary as well as, at the Board’s
discretion, a stock bonus for each fiscal year (running from January 1 to
December 31) during your employment based upon performance. Bonus criteria are
to be agreed upon within three (3) months of the signature date of this
employment agreement. Performance for bonus purposes during succeeding years
will be measured against a set of criteria or milestones to be approved by the
Board of Directors no later than December 31 of the preceding year.

 1
 

3.                                       Benefits.
You will be eligible for the benefits package available to company executives,
as such may be altered from time to time by Linguagen, so long as you and/or
your dependents meet all eligibility requirements. Enclosed is a summary of
those benefits. You will also be entitled to annual vacation of up to 20 days,
accruing in accordance with regular company policy as outlined in the Linguagen
Employee Handbook. In addition, you will be able to take up to seven (7) days
per annum in performance of duties for other Companies, Federal Advisory
Boards, etc., providing that these activities do not represent any conflicts
with the performance of your duties for Linguagen.

4.                                       Expense
Reimbursement. The Company shall reimburse you for all reasonable
out-of-pocket expenses which you incur on behalf of the Company, provided that
you furnish to the Company reasonably adequate records and documentary evidence
of such expense.

5.                                       Long-Term
Incentive Compensation. As of the date on which you commence employment,
you shall receive the following grant in accordance with the terms of the
Company’s Stock Option Plan, a copy of which is attached hereto as Exhibit B.

a.               Stock
Option: You will be granted a stock option to purchase 213,500 shares of
Linguagen common stock. The Option will have an exercise price equal to the
fair market value (currently $0.42 per share) of the underlying common stock on
the date of grant. The Option will vest as follows: (i) twenty five percent
(25%) of the Option shall vest on the first anniversary of your first day of
employment with Linguagen; and (ii) 1/48th of the Option
shall vest on the first day of each month beginning with the thirteenth month
following your first day of employment with Linguagen. The entire Option shall
vest over a period of four (4) years and have a maximum term of 10 years. As
with all Linguagen options, the grant will be subject to the stock option plan
and the execution of a stock option agreement in the form specified by the
Board.

b.              Annual
Awards. You will be eligible to participate in the Company’s annual awards to
executives of long-term incentive compensation, should the Company elect to
establish an equity incentive plan. Awards will be based upon performance as
determined by the Board’s Compensation Committee. In addition, immediately
following the completion of the contemplated Series B Financing, the Board will
review your equity position as part of its review of the equity position of
each member of the management team.

6.                                       Change
of Control. Immediately upon an acquisition of the Company by merger, the
sale of all or substantially all of the Company’s assets, or the purchase of
fifty percent (50%) or more of the Company’s voting securities or any other
reorganization resulting in a change of fifty percent (50%) or more in the
ownership of the Company’s outstanding voting securities (any such action
hereinafter to be referred to as a “Change of Control”), regardless of whether
or not you shall have voted for such Change of Control as a stockholder or
consented thereto in writing, all of your unvested options shall immediately
vest and become exercisable.

 2
 

7.                                       Term
of Employment. Your employment with the Company is “at will” and not for
any specified period of time. As a result, either you or the Company are free
to terminate your employment at any time for any reason, with or without cause,
by giving written notice of such termination.

8.                                       Effect
of Termination. If the Company terminates your employment “Without Cause”
(defined below), then you will continue to receive your base salary (based on
your base salary prevailing at the time of termination), benefits and the
vesting of stock options for six (6) months from the date of such termination
of your employment (hereafter, the “Severance Period”).

If you are terminated for “Cause” (defined below) or you resign at any
time, then you would only be paid all salary and benefits through the date of
termination of your employment.

As used in this Section, a termination for “Cause” shall mean a
termination for any of the following reasons: (i) engaging in intentional
misconduct which materially harms the Company; (ii) being convicted of a felony
that has, or may have, a material adverse effect on your ability to render
services to the Company; (iii) committing an act of fraud against the Company
or the willful material misappropriation of property belonging to the Company; (iv)
materially breaching the Confidentiality, Nondisclosure, Noncompetition and
Invention Assignment Agreement or any other agreement between you and the
Company; or (v) persistently and willfully disregarding your material duties
despite adequate warnings from senior management or the Board. With respect to
a violation or breach as specified under clauses (iv) or (v) above, “Cause”
shall not exist unless you fail to cure such breach or misconduct within twenty
(20) days after you are given written notice from the Company specifying such
breach and stating that your failure to cure such breach or misconduct will
constitute Cause for termination under this agreement. The Company will provide
written notice of the reason for termination in the case of any termination for
“Cause.” A termination for any other reason shall be a termination “Without
Cause.” This regard of duties shall not be interpreted to include any failure
to meet sales milestones or other goals established by the Company. An action
will not be deemed willful unless performed by the employee in bad faith.

9.                                       Arbitration.
Any and all disputes between us which arise out of your employment, the
termination of your employment, or under the terms of this agreement shall be
resolved through final and binding arbitration. This shall include, without
limitation, disputes relating to this agreement, any disputes regarding your
employment by the Company or the termination thereof, claims for breach of
contract or breach or the covenant of good faith and fair dealing, and any
claims of discrimination or other claims under any federal, state or local law
or regulation now in existence or hereinafter enacted and as amended from time
to time concerning in any way the subject of your employment with the Company or
its termination. The only claims not covered by this section are the following:
(i) claims for benefits under the unemployment insurance or worker’s
compensation laws and (ii) claims concerning the validity, infringement or
enforceability of any trade secret, patent right, copyright, trademark or any
other intellectual property held or sought by the Company, or which the Company
could otherwise seek; in each of these instances such disputes or claims shall
not be subject to arbitration, but rather, will be resolved pursuant to
applicable law. Binding arbitration will be conducted in Philadelphia,
Pennsylvania. The cost of arbitration will be bourn by the Company. The
arbitration will be conducted in accordance with the rules and regulations of
the American Arbitration Association. The prevailing party shall be awarded its
attorneys’ fees and costs and arbitration related expenses from the
non-prevailing party. You understand and agree that arbitration shall be
instead of any civil litigation, that each side waives its right to a jury
trial, and that the arbitrator’s decision shall

 3
 

be final and binding to the fullest extent permitted by law and
enforceable by any court having jurisdiction thereof.

10.                                 Miscellaneous.
This Agreement and the rights and obligations of the parties shall be governed
by New Jersey law. Neither party may assign this agreement. In the event that
either party believes that the other party has breached this agreement in any
way, the party claiming such breach shall give written notice and thirty day
opportunity to cure such breach, in the event such breach is curable.

We sincerely hope you
will accept our offer: please indicate your acceptance by signing both copies
of this letter, returning one to me and retaining the other for your records.
If you have any questions concerning this position, please feel free to speak
with me.

Sincerely yours,

	
  /s/ F. Raymond Salemme

  	
   

  

F. Raymond Salemme

Chief Executive Officer 

	
  Accepted: 

  	
  /s/ Sue Barrow Welsh

  	
   

  	
  Date: 

  	
  12/28/05

  
	
   

  	
   

  	
   

  	
   

  
	
  Agreeable Starting Date: 

  	
  1/3/06

  	
   

  	
   

  
						

 

cc:           Linguagen Compensation Committee

 4Exhibit 10.13

	
  

  
	
  2005 Eastpark Boulevard

  
	
  Cranbury, NJ 08512-3515

  
	
  Tel 1609)860-1500

  
	
  Fax (609)860-5900

  
	
  www.linguagen.com

  

 

June 28, 2004

Scott Horvitz

7 Timber Knoll Drive

	
  Washington Crossing, PA 18977

  	
   

  	
  via fedex: 215-321-5928

  

Dear Scott:

On behalf of the Board of
Directors, I am pleased to offer you the position of Chief Financial Officer,
Corporate Secretary and Treasurer with Linguagen Corp. (“Linguagen” or the “Company”).
This letter sets forth the terms of your employment by the Company, with your
first day of employment being July 1, 2004.

1.                                       Position, Duties and Responsibilities 

a.               You will report to the Chief Executive
Officer of the Company.

b.              On or before your first day of employment,
you shall sign the Company’s Confidentiality, Nondisclosure, Noncompetition and
Invention Assignment Agreement for employees, a copy of which is attached
hereto as Exhibit A.

2.                                       Salary and Bonus Compensation 

a.               Base Salary: Your base salary will be $17,250
per month ($207,000/year), payable bi-weekly. This base salary may be adjusted
annually by the Board beginning in January 2005, consistent with your
performance and the Company’s policy regarding adjustments in officer
compensation established from time to time by the Board.

b.              Bonus Compensation. You will, in addition, be
eligible for a cash bonus of up to thirty per cent (30%) of your base salary as
well as, at the Board’s discretion, a stock bonus for each fiscal year (running
from January 1 to December 31) during your employment based upon performance.
The bonus for 2004 is to be prorated based on six twelfths (6/12) of the full
year bonus eligibility. Bonus criteria for 2004 are to be agreed upon within
three (3) months of the signature date of this employment agreement.
Performance for bonus purposes during succeeding years will be measured against
a set of criteria or milestones to be approved by the Board of Directors no
later than December 31 of the preceding year.

3.                                     Benefits.
You will be eligible for the benefits package available to company executives,
as such may be altered from time to time by Linguagen, so long as you and/or
your dependents meet all eligibility requirements. Presently these benefits
include health care insurance coverage for yourself and your family, sick days,
paid holidays, and four (4) weeks of annual vacation, all in accordance with
our corporate policies, which of course may change over time. In addition, you
will be able to take up to seven (7) days per annum in performance of duties
for other Companies, Federal Advisory Boards, etc., providing that these
activities do 

 1
 

not represent any
conflicts with the performance of your duties for Linguagen.

4.                                       Expense Reimbursement The Company shall reimburse you for all
reasonable out-of-pocket expenses which you incur on behalf of the Company,
provided that you furnish to the Company reasonably adequate records and
documentary evidence of such expense.

5.                                     Long-Term Incentive Compensation. As of the date on which you commence
employment, you shall receive the following grant in accordance with the terms
of the Company’s Stock Option Plan, a copy of which is attached hereto as Exhibit
B.

a.               Stock Option: You will be granted a stock
option to purchase an aggregate number of shares of Linguagen common stock
equal to one and one-half per cent (1.5%) of the fully diluted equity of the
Company following the closing of our Series A financing and concurrent
enlargement of our option pool (the “Option”). Fully diluted equity includes
all shares reserved for issuance pursuant to our plan. The Option will have an
exercise price equal to the fair market value (currently $0.42 per share) of
the underlying common stock on the date of grant. This Option shall be subject
to and conditioned upon the approval of Linguagen’s stockholders increasing the
number of shares that may be issued under the Company’s Stock Option Plan. The
estimated total number of shares outstanding after the completion of the Series
A financing and expansion of the Common Option pool is estimated to be
approximately 10,658,656 shares. The Option will vest as follows: (i) twenty
five percent (25%) of the Option shall vest on the first anniversary of your
first day of employment with Linguagen; and (ii) 1/48th of the Option shall vest on the first day of
each month beginning with the thirteenth month following your first day of
employment with Linguagen. The entire Option shall vest over a period of four
(4) years have a maximum term of 10 years. As with all Linguagen options, the
grant will be subject to the stock option plan and the execution of a stock
option agreement in the form specified by the Board.

b.              Annual Awards. You will be eligible to
participate in the Company’s annual awards to executives of long-term incentive
compensation, should the Company elect to establish an equity incentive plan.
Awards will be based upon performance as determined by the Board’s Compensation
Committee.

6.                                     Change of Control. Immediately upon an acquisition of the
Company by merger, the sale of all or substantially all of the Company’s
assets, or the purchase of fifty percent (50%) or more of the Company’s voting
securities or any other reorganization resulting in a change of fifty percent
(50%) or more in the ownership of the Company’s outstanding voting securities
(any such action hereinafter to be referred to as a “Change of Control”),
regardless of whether or not you shall have voted for such Change of Control as
a Director or stockholder or consented thereto in writing, all of your unvested
options shall immediately vest and become exercisable.

7.                                     Term of Employment. Your employment with the Company is “at
will” and not for any specified period of time. As a result, either you or the
Company are free to terminate your employment at any time for any reason, with
or without cause, by giving written notice of such termination.

8.                                     Effect of Termination. If the Company terminates your employment “Without
Cause” (defined below), then you will continue to receive your base salary
(based on your base salary prevailing at the time of termination), benefits and
the vesting of stock options for twelve (12) months from the date of such
termination of your employment (hereafter, the “Severance Period”).

 2
 

If you are
terminated for “Cause” (defined below) or you resign at any time, then you
would only be paid all salary and benefits through the date of termination of
your employment. 

As used in
this Section, a termination for “Cause” shall mean a termination for any of the
following reasons: (i) engaging in intentional misconduct which materially
harms the Company; (ii) being convicted of a felony; (iii) committing an act of
fraud against the Company or the willful material misappropriation of property
belonging to the Company; (iv) materially breaching the Confidentiality,
Nondisclosure, Noncompetition and Invention Assignment Agreement or any other
agreement between you and the Company; or (v) willfully disregarding your
material duties despite adequate warnings from the Board. With respect to a
violation or breach as specified under clauses (iv) or (v) above, “Cause” shall
not exist unless you fail to cure such breach or misconduct within twenty (20)
days after you are given written notice from the Company specifying such breach
and stating that your failure to cure such breach or misconduct will constitute
Cause for termination under this agreement. The Company will provide written
notice of the reason for termination in the case of any termination for “Cause.”
A termination for any other reason shall be a termination “Without Cause.” This
regard of duties shall not be interpreted to include any failure to meet sales
milestones or other goals established by the Company. An action will not be
deemed willful unless performed by the employee in bad faith.

9.                                     Arbitration. Any and all disputes between us which arise out of your employment,
the termination of your employment, or under the terms of this agreement shall
be resolved through final and binding arbitration. This shall include, without
limitation, disputes relating to this agreement, any disputes regarding your
employment by the Company or the termination thereof, claims for breach of
contract or breach or the covenant of good faith and fair dealing, and any
claims of discrimination or other claims under any federal, state or local law
or regulation now in existence or hereinafter enacted and as amended from time
to time concerning in any way the subject of your employment with the Company
or its termination. The only claims not covered by this section are the following:
(i) claims for benefits under the unemployment insurance or worker’s
compensation laws and (ii) claims concerning the validity, infringement or
enforceability of any trade secret, patent right, copyright, trademark or any
other intellectual property held or sought by the Company, or which the Company
could otherwise seek; in each of these instances such disputes or claims shall
not be subject to arbitration, but rather, will be resolved pursuant to
applicable law. Binding arbitration will be conducted in Philadelphia,
Pennsylvania. The cost of arbitration will be bourn by the Company. The
arbitration will be conducted in accordance with the rules and regulations of
the American Arbitration Association. The prevailing party shall be awarded its
attorneys’ fees and costs and arbitration related expenses from the
non-prevailing party. You understand and agree that arbitration shall be
instead of any civil litigation, that each side waives its right to a jury
trial, and that the arbitrator’s decision shall be final and binding to the
fullest extent permitted by law and enforceable by any court having
jurisdiction thereof.

10.                               Miscellaneous. This Agreement and the rights and
obligations of the parties shall be governed by New Jersey law. Neither party
may assign this agreement. In the event that either party believes that the
other party has breached this agreement in any way, the party claiming such
breach shall give written notice and thirty day opportunity to cure such
breach, in the event such breach is curable.

 3
 

We sincerely hope you will accept our offer: please indicate
your acceptance by signing both copies of this letter, returning one to me and
retaining the other for your records. If you have any questions concerning this
position, please feel free to speak with me.

Sincerely yours,

	
  /s/ F. Raymond Salemme

  	
   

  

F. Raymond
Salemme

Chief Executive Officer

 

	
  Accepted:

  	
  /s/ Scott Horvitz

  	
   

  	
   

  	
  Date:

  	
  6/28/04

  

 

	
  Agreeable Starting Date:

  	
  July 1, 2004

  	
   

  	
   

  

cc:
Linguagen Compensation Committee

 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00119-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00119-of-00352.parquet"}]]